Adjuvant Holdings Co.,Ltd. (TYO:4929)

Adjuvant Holdings Revenue

Adjuvant Holdings had revenue of 1.05B JPY in the quarter ending June 20, 2026, with 9.71% growth. This brings the company's total for the last twelve months to 3.91B, down -2.20% year-over-year. In the fiscal year ending March 20, 2026, Adjuvant Holdings had annual revenue of 3.81B, down -6.95%. That makes Adjuvant Holdings the 32,547th largest company in the world by revenue and 3,399th in Japan.

• Revenue (ttm): 3.91B
• Revenue Growth: -2.20%
• P/S Ratio: 1.56
• Revenue / Employee: 31.76M
• Employees: 123
• Market Cap: 6.08B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Japan 3.65B 95.9%
• Overseas 158.00M 4.1%

Fiscal year ended Mar 20, 2026 See the full Adjuvant Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 20, 2026	3.81B	-285.00M	-6.95%
Mar 20, 2025	4.10B	-340.00M	-7.66%
Mar 20, 2024	4.44B	61.00M	1.39%
Mar 20, 2023	4.38B	-50.00M	-1.13%
Mar 20, 2022	4.43B	-458.00M	-9.38%

Data Source: S&P Global Market Intelligence Last updated: Jul 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error